TY - JOUR
KW - Antiviral Agents
KW - Azithromycin
KW - Coronavirus Infections
KW - Humans
KW - Administration, Oral
KW - Child, Preschool
KW - Infant
KW - Mass Drug Administration
KW - Coronavirus
KW - Viral Load
KW - Infant, Newborn
KW - Nasopharynx
KW - Nigeria
AU - Thuy Doan
AU - Armin Hinterwirth
AU - Ahmed Arzika
AU - Lee Worden
AU - Cindi Chen
AU - Lina Zhong
AU - Catherine Oldenburg
AU - Jeremy Keenan
AU - Thomas Lietman
AB - <p>We evaluated the potential antiviral effects of azithromycin on the nasopharyngeal virome of Nigerien children who had received multiple rounds of mass drug administration. We found that the respiratory burden of non-severe acute respiratory syndrome coronaviruses was decreased with azithromycin distributions. Clinical Trials Registration. NCT02047981.</p>

BT - Clin Infect Dis
DA - 2020 11 19
DO - 10.1093/cid/ciaa606
IS - 16
J2 - Clin Infect Dis
LA - eng
N2 - <p>We evaluated the potential antiviral effects of azithromycin on the nasopharyngeal virome of Nigerien children who had received multiple rounds of mass drug administration. We found that the respiratory burden of non-severe acute respiratory syndrome coronaviruses was decreased with azithromycin distributions. Clinical Trials Registration. NCT02047981.</p>

PY - 2020
SP - 2282
EP - 2284
T2 - Clin Infect Dis
TI - Reduction of Coronavirus Burden With Mass Azithromycin Distribution.
VL - 71
SN - 1537-6591
ER -